Zurueck zur Suche

Reporte zur Charge U029319

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

18Reporte angezeigt
0Todesfaelle
1Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
IN 5 IL 5 PA 2 MI 2 NJ 1 ME 1 NH 1 VA 1

VAERS 2206601

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U029319

moderat
Staat
PA
Alter
4,0
Geschlecht
M
Eingang
30.03.2022
Impfdatum
28.01.2022
Beginn
28.01.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Abdominal discomfort Abdominal pain upper Amnesia Anal incontinence Anger Blood test Cognitive disorder Dysgraphia Dyskinesia Electroencephalogram abnormal Encephalopathy Eye pain Fatigue Feeling abnormal Feeling hot Gait inability Hallucination Hallucination, auditory

Symptomtext

1/28/2022 - 5 PM - Patient stated upset/pain in stomach, not long afterwards he vomited, still felt bad and continued to vomit and increased fatigue. Vomitted 2-3 more time through the night. Lost Bowel control and incontinent 1/29/2022 - appeared exhauseted, no temperature - napped at 10am (does not typically nap) woike up 30 min later yelling with hallucinations, was hot and sweaty and involuntary body movements - shaking uncontrollablly. Lost sensations - could not feel cold, couldnt walk, contacted 24 hour nurse and was seen at the Emergency Room. Hallucinations and distorted images continued through 1/30/2022 Admitted to hospital for 3 days and discharged 2/3/20222 After discharge Short term memory loss, fatigue, constant headache, stomach aches and pain behind eyes contnued 2/4/2022 - hearing voices, music that made him angry (no hearing loss) and pressure headaches and distorted images - Saw Dr. on 2/7/2022 referred to Neurology and seen at Neurology 2/8/2022 Symptoms Continued through February End of february halluciantions and distored images began to improve March continued with Neurology, no new symptoms, but headaches contnue, fatigue with strenousous activity, writing things backwards and slower comprehension (not normal for patient) - Patient has lost bowel and bladder control in night hours (Patient was fully potty trained at 1.5 years - this is a new symptom) Diagnosis: Encephalopathy acute

Weitere VAERSDATA-Felder
Praegender Schweregrund
Tremor
Hospital-Tage
3,0
Labordaten
BloodWork Labs at hospital and repeated EEG completed on 2/24/2022 with Neurology - Abnormal Results Patient prescribed Dilantinby neurology
Aktuelle Erkrankungen
None
Vorgeschichte
None prior to immunization
Andere Medikamente
None
Allergien
NKDA or NKA
Vorherige Impfungen
-

VAERS 2396506

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U029319

mild
Staat
MI
Alter
1,0
Geschlecht
M
Eingang
29.07.2022
Impfdatum
11.05.2022
Beginn
01.05.2022
Tage bis Beginn
-
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Abscess drainage COVID-19 Fluid retention Haematoma Injection site mass Iron deficiency anaemia Lymphadenopathy Mass Oedema Purulent discharge Respiratory tract congestion Ultrasound Doppler abnormal

Symptomtext

Pt developed lump in bilateral thighs. Was not immediately reported by parents, unknown when lumps developed. Pt seen in office 6/15/22 for deceleration in weight gain. 6/27/22 pt started on iron supplement for iron deficiency anemia. Pt seen again 7/7/22 for mass of both thighs and congestion. US ordered and to be done when family returns back from vacation over this next weekend. Pt seen 7/20/22 for abscess. Mother notes that the left side area opened up and began draining purulent material, and mother notes that it is now significantly decreased in size. Pt developed COVID 19 and subsequently ultrasound not completed until 7/28/22.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site mass
Hospital-Tage
-
Labordaten
ultrasound 7/28/22 CLINICAL INDICATIONS: Right and left anterior thigh lumps. COMPARISON: No prior exams are available for comparison. FINDINGS: Scanning over the right anterior thigh lumps reveal multiple complex fluid collections, including a 2.1 x 1.9 x 1.2 cm collection and a 2.0 x 1.2 x 0.8 cm collection in the subcutaneous fat. Color Doppler analysis reveals increased vascularity at the periphery of these fluid collections. There is also a borderline enlarged 18 x 8 x 5 mm lymph node. There is a 4.0 x 3.0 x 1.1 cm complex fluid collection in the anterior left thigh subcutaneous fat with peripheral vascularity on color Doppler analysis. IMPRESSION: There are 2 complex fluid collections in the anterior right thigh subcutaneous fat measuring 2.1 and 2.0 cm which may represent hematomas or small abscesses. 4.0 cm anterior left thigh subcutaneous complex fluid collection is also consistent with abscess or hematoma
Aktuelle Erkrankungen
Rash on back
Vorgeschichte
-
Andere Medikamente
None
Allergien
NKA
Vorherige Impfungen
-

VAERS 2612720

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U029319

gering
Staat
NJ
Alter
-
Geschlecht
U
Eingang
11.04.2023
Impfdatum
-
Beginn
21.03.2023
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE; Product was 2 days post expiry date and administered to a patient.; This spontaneous report was received from a Licensed Practical Nurse (L.P.N), referring to a patient of unknown age and gender. Information of the patient's medical history, concurrent condition, drug reaction/allergy and concomitant therapy was not reported. On 21-MAR-2023, the patient was administrated with the 1st dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant Human albumin (rHA) (PROQUAD) injection (lot #U029319, expiration date: 19-MAR-2023, strength, anatomical location and route of administration were not reported) for prophylaxis (expired product administered). No additional adverse event (AE) occurred.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2557731

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U029319

gering
Staat
MI
Alter
0,2
Geschlecht
F
Eingang
11.01.2023
Impfdatum
14.02.2022
Beginn
14.02.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration

Symptomtext

Reporting this as this has come to my desk. Patient received doses outside of their normal vaccination dates. Pt parents were not contacted due to unknown adverse event.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2513720

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U029319

gering
Staat
IL
Alter
4,0
Geschlecht
M
Eingang
22.11.2022
Impfdatum
18.10.2022
Beginn
18.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE.; an improperly stored vaccine was administered to a patient; This spontaneous report was received from a registered nurse and refers to a 4-year-old male patient. The patient's concurrent conditions or medical history was not provided. On 18-OCT-2022 the patient was vaccinated with improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) recombinant human albumin (rHA) (lot # U029319, expiration date: 19-MAR-2023),0.5 milliliter, subcutaneous in the right vastus lateralis for prophylaxis. The same day the patient was also vaccinated with improperly stored diphtheria vaccine toxoid, pertussis vaccine acellular 3-component, polio vaccine inact 3v (vero), tetanus vaccine toxoid (KINRIX) and influenza vaccine. Patient also received COVID 19 vaccine on 26-SEP-2022. Administered dose of vaccine experienced the temperature excursion of 10.8 degrees Fahrenheit (F) for 18 hours 30 minutes. There was no previous temperature excursion. There was no adverse event reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2369198

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U029319

gering
Staat
ME
Alter
5,0
Geschlecht
F
Eingang
14.07.2022
Impfdatum
19.04.2022
Beginn
19.04.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

Patient received a sub-optimal COVID-19 vaccine due to a storage and handling error. Vaccine was stored in a regular freezer prior to being refrigerated and then administered. The regulatory authority requested that a VAERS form be submitted for this patient.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2325040

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U029319

gering
Staat
NH
Alter
-
Geschlecht
F
Eingang
21.06.2022
Impfdatum
27.05.2022
Beginn
27.05.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age Wrong product administered

Symptomtext

no adverse event; patient received PROQUAD instead of MMR II; patient received PROQUAD instead of MMR II; This spontaneous report was received from a medical assistant referring to a 30-year-old female. The patient's concurrent conditions, medical history, allergies and concomitant therapies were not reported. On 27-MAY-2022, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) subcutaneous injection, 1 dose, (lot #U029319 has been verified to be valid, expiration date 19-MAR-2023, administered for prophylaxis (strength, and route of administration were not provided) (product administered to patient of inappropriate age), instead of received measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (Wrong product administered) this was supposed to be her first dose of the M-M-R II vaccine. It was reported that the patient had a previous positive varicella titer but it was unknown if she had natural immunity or vaccine-induced immunity. No adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Serology positive (It was unknown if she had natural immunity or vaccine-induced immunity.)
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2312410

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U029319

gering
Staat
IN
Alter
-
Geschlecht
U
Eingang
08.06.2022
Impfdatum
03.05.2022
Beginn
03.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

PROQUAD being administered after an excursion; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's concomitant medications, medical history, concurrent conditions, drug reactions or allergies were not reported. On 03-MAY-2022, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant Human albumin) (PROQUAD) subcutaneous injection, 0.5 ml, lot #U029319, expiration date: 19-MAR-2023 (anatomical location and route of administration were not provided) for prophylaxis, after the vaccine undergone temperature excursion in -2 Celsius degrees (C) for 1 hour and 12 minutes (on 25-APR-2022) (Product storage error). Previous temperature excursions were as follows: -10 C up to 8 C (7.3C) for 2 hours 37 minutes 0 seconds, and -10 C up to 8 C (0.7C) for 2 hours 56 minutes 0 seconds. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2205USA002581: US-009507513-2205USA002473: US-009507513-2205USA002531: US-009507513-2205USA002678: US-009507513-2205USA002635:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2286355

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U029319

gering
Staat
IN
Alter
-
Geschlecht
U
Eingang
20.05.2022
Impfdatum
27.04.2022
Beginn
27.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

PROQUAD being administered after an excursion that occurred on 4/25/2022; This spontaneous report was received from a medical assistant and refers to a patient of unspecified age and gender. The patients' concomitant medications, pertinent medical history, concurrent conditions, drug reactions or allergies were not reported. On 27-APR-2022, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant Human albumin) (PROQUAD) subcutaneous injection, 0.5 ml, lot #U029319, expiration date: 19-MAR-2023 (anatomical location and route of administration were not provided) for prophylaxis, after the vaccine undergone temperature excursion in -2 Celsius degrees (C) for 1 hour and 12 minutes on 25-APR-2022 (Product storage error). Previous temperature excursions were as follows: -10 C up to 8 C (7.3C) for 2 hours 37 minutes 0 seconds, and -10 C up to 8 C (0.7C) for 2 hours 56 minutes 0 seconds.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2284439

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U029319

gering
Staat
IN
Alter
-
Geschlecht
U
Eingang
19.05.2022
Impfdatum
27.04.2022
Beginn
27.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

PROQUAD administered after an excursion that occurred on 4/25/2022.; This spontaneous report was received from a medical assistant referring to a patient of unspecified age and gender. The patient's concurrent conditions, medical history, and concomitant therapies were not reported. On 25-APR-2022, Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) vaccines experienced a temperature excursion for 1 hour and 12 minutes, at -2 degree Celsius (product storage error). The vaccines underwent a previous temperature excursion at -10 degree Celsius up to 8 degree Celsius (7.3C) for 2 hours and 37 minutes, and at -10 C up to 8 C (0.7 C) for 2 hours and 56 minutes. On 27-APR-2022, the patient was vaccinated with the improperly stored dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) 0.5 ml, Lot number: U029319, expiration date: 19-MAR-2023, (strength, vaccination scheme, frequency, route of administration, and anatomical location were not provided), for prophylaxis. This is one of several reports received from the same reporter.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2277391

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U029319

gering
Staat
IN
Alter
-
Geschlecht
U
Eingang
14.05.2022
Impfdatum
05.05.2022
Beginn
25.04.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Caller reporting an AE for PROQUAD being administered after an excursion; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 25-APR-2022, it was stated that measles, mumps, rubella, and varicella (OKA-MERCK) virus vaccine live recombinant human albumin (rHA) (PROQUAD) was storage in a temperature of minus (-)10 Celsius degree (C)) up to 8C (7.3 C) for 2 hours 37 minutes 0 seconds; then a temperature excursion (temperature -2 C) (Incorrect product storage) occurred during 1 hour and 12 minutes. After the excursion, the vaccine temperature was reported as -10C up to 8C (0.7 C) for 2 hours 56 minutes 0 seconds. On 05-MAY-2022, the patient was vaccinated with measles, mumps, rubella, and varicella (OKA-MERCK) virus vaccine live recombinant human albumin (rHA) (PROQUAD) (lot #U029319 has been verified to be valid, expiration date: 19-MAR-2023) 0.5 milliliter (strength and route of administration were not provided) as prophylaxis.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2277359

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U029319

gering
Staat
PA
Alter
-
Geschlecht
U
Eingang
14.05.2022
Impfdatum
22.03.2022
Beginn
22.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No other AE; Caller is a nurse who reports a dose of PROQUAD was given to a patient following temperature excursion.; This spontaneous report has been received from a registered nurse concerning a patient of unknown age and gender. The patient's pertinent medical history, concomitant medications, previous drug reactions or allergies were not provided. On 22-MAR-2022 the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin rHA) (PROQUAD) 0.5 ml once, administered as prophylaxis, lot number U029319 was verified to be a valid lot number, expiration date: 19-MAR-2023 (route of administration and anatomical location were not reported), the vial was reconstituted with sterile diluent (MERCK STERILE DILUENT) (strength, dose, lot number and expiry date were not reported) (product storage error). The measles, mumps, rubella and varicella (oka merck) virus vaccine live (PROQUAD) was stored at a temperature of -11.7 Celsius (C) for the time frame of 49 minutes. There was no previous temperature excursion. No further adverse event (AE) was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
MERCK STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2273003

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U029319

gering
Staat
IN
Alter
-
Geschlecht
U
Eingang
12.05.2022
Impfdatum
03.05.2022
Beginn
03.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Caller reporting an AE for PROQUAD being administered after an excursion that occurred on 4/25/2022.; This spontaneous report aws received from a medical assistant and refers to a patient of unknown age. The patient's concurrent conditions, drug reactions or allergies, pertinent medical history and concomitant therapy were not reported. On 25-APR-2022, measles, mumps, rubella and varicella (oka-merck) virus vaccine live, (rHA) (PROQUAD), was exposed to -2 Celsius (C) during 1 hour and 12 minutes. Also, the vaccine had previous temperatures excursions: -10?C up to 8?C (7.3C) for 2 hours 37 minutes 0 seconds and -10?C up to 8?C (0.7C) for 2 hours 56 minutes 0 seconds. On 03-MAY-2022, the patient was vaccinated with an incorrect storage dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live, (rHA) (PROQUAD), lot # U029319, expiration date 13-MAR-2023, 0.5 milliliter (route was not reported) (storage error) for prophylaxis. There was no product quality complain reported. Thias is one of several reports form the same reporter.; Sender's Comments: US-009507513-2205USA002635: US-009507513-2205USA002473: US-009507513-2205USA002581: US-009507513-2205USA002746: US-009507513-2205USA002531:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2242831

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U029319

gering
Staat
IL
Alter
-
Geschlecht
U
Eingang
20.04.2022
Impfdatum
07.04.2022
Beginn
07.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported; A vaccine coordinator reported PROQUAD was administered after a temperature excursion.; This spontaneous report was received from a vaccine coordinator referring to a patient of unknown age and gender. Concomitant medication, pertinent medical history and drug reactions/allergies were not reported. On 07-APR-2022, the patient was vaccinated with improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin (rHA)) (PROQUAD) (strength, dose and route were not reported; lot # U029319, expiration date: 19-MAR-2023) for prophylaxis (product storage error). It was reported that the suspect vaccine was exposed to a temperature of minus 11.83 degree Celsius for a time frame of 15 minutes. The previous temperature excursion included 9.37 degree Celsius for a time frame of 2 hours and 30 min. No additional adverse event (AE) information was provided (no adverse event). This is one of the multiple cases reported by the same reporter.; Sender's Comments: US-009507513-2204USA002815:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2238260

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U029319

gering
Staat
IL
Alter
-
Geschlecht
U
Eingang
18.04.2022
Impfdatum
04.04.2022
Beginn
04.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported; A vaccine coordinator reported PROQUAD was administered after a temperature excursion.; This spontaneous report was received from a vaccine coordinator referring to a patient of unknown age and gender. Concomitant medication, pertinent medical history and drug reactions/allergies were not reported. On 04-APR-2022, the patient was vaccinated with improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin (rHA)) (PROQUAD) (strength, dose and route were not reported; lot # U029319, expiration date: 19-MAR-2023) for prophylaxis (product storage error). It was reported that the suspect vaccine was exposed to a temperature of minus 11.83 degree Celsius for a time frame of 15 minutes. The previous temperature excursion included 9.37 degree Celsius for a time frame of 2 hours and 30 min. No additional adverse event (AE) information was provided (no adverse event). This is one of the multiple cases reported by the same reporter.; Sender's Comments: US-009507513-2204USA002815:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2238259

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U029319

gering
Staat
IL
Alter
-
Geschlecht
U
Eingang
18.04.2022
Impfdatum
04.04.2022
Beginn
04.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported; A vaccine coordinator reported PROQUAD was administered after a temperature excursion.; This spontaneous report was received from a vaccine coordinator referring to a patient of unknown age and gender. Concomitant medication, pertinent medical history and drug reactions/allergies were not reported. On 04-APR-2022, the patient was vaccinated with improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin (rHA)) (PROQUAD) (strength, dose and route were not reported; lot # U029319, expiration date: 19-MAR-2023) for prophylaxis (product storage error). It was reported that the suspect vaccine was exposed to a temperature of minus 11.83 degree Celsius for a time frame of 15 minutes. The previous temperature excursion included 9.37 degree Celsius for a time frame of 2 hours and 30 min. No additional adverse event (AE) information was provided (no adverse event). This is one of the multiple cases reported by the same reporter.; Sender's Comments: US-009507513-2204USA002815:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2237178

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U029319

gering
Staat
IL
Alter
-
Geschlecht
U
Eingang
16.04.2022
Impfdatum
25.03.2022
Beginn
25.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported; A vaccine coordinator reported PROQUAD was administered after a temperature excursion.; This spontaneous report was received from a vaccine coordinator referring to a patient of unknown age and gender. Concomitant medication, pertinent medical history and drug reactions/allergies were not reported. On 25-MAR-2022, the patient was vaccinated with improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin (rHA)) (PROQUAD) (strength, dose and route were not reported; lot # U029319, expiration date: 19-MAR-2023) for prophylaxis (product storage error). It was reported that the suspect vaccine was exposed to a temperature of minus 11.83 degree Celsius for a time frame of 15 minutes; Previous temperature excursion included 9.37 degree Celsius for a time frame of 2 hours and 30 min. No additional adverse event (AE) information was provided (no adverse event). This is one of the multiple cases reported by the same reporter.; Sender's Comments: US-009507513-2204USA002815:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2192342

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U029319

gering
Staat
VA
Alter
4,0
Geschlecht
M
Eingang
22.03.2022
Impfdatum
22.03.2022
Beginn
22.03.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Heart rate increased Pallor Wheezing

Symptomtext

wheezing all lobes, responsive, pale with increased heartrate. Pulse ox 76, oxygen started open full, epi-pen 0.15mg given left thigh. Pt's pulse ox increased to 95%.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Heart rate increased
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-